1. Chang YC, Nagasue N, Abe S, Taniura H, Kumar DD, Nakamura T (1992) Comparison between the clinicopathologic features of AFP-positive and AFP-negative gastric cancers. Am J Gastroenterol 87:321–325
2. Mihmanli M, Dilege E, Demir U, Coskun H, Eroglu T, Uysalol MD (2004) The use of tumor markers as predictors of prognosis in gastric cancer. Hepatogastroenterology 51:1544–1547
3. Lukinac L, Bolanca A, Nothig-Hus D, Kusic Z (1997) Follow-up of patients with gastrointestinal cancer by tumor marker determination. Acta Med Croatica 51:73–77
4. Takahashi Y, Takeuchi T, Sakamoto J, Touge T, Mai M, Ohkura H, Kodaira S, Okajima K, Nakazato H (2003) Tumor Marker Committee: the usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study. Gastric Cancer 6:142–145
5. Kono K, Amemiya H, Sekikawa T, Iizuka H, Takahashi A, Fujii H, Matsumoto Y (2002) Clinicopathologic features of gastric cancers producing alpha-fetoprotein. Dig Surg 19:359–365